Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 9, 2014, Pages 719-729

  Vimaleswaran, K S ^a,b   Cavadino, A ^a   Berry, D J ^a   Power, C ^a   Hypponen E ^a,ca,cb   Jorde, R ^c   Grimnes, G ^c   Dieff enbach, A K ^d   Schottker B ^d   Saum, K U ^d   Brenner, H ^d   Lu, C ^e   Jarvelin M R ^{f,h,aq,ar,at,au,av}   Tzoulaki, I ^g   Heerspink, H J L ^i,j   Nolte, I M ^j   Snieder, H ^j   van der Most, P J ^j   Stolk, R P ^j   Hartman, C A ^j   de Boer, R A ^k   van der Harst, P ^k   Navis, G ^j   de Borst, M H ^j   Tikkanen, E ^k,l,bb,bc   Eriksson, J ^m   Lorentzon, M ^m   Mellstrom D ^m   Ohlsson, C ^m   Wong, A ⁿ   Hardy, R ⁿ   Kuh, D ⁿ   Cooper, J A ^o   Acharya, J ^o   Humphries, S E ^o   Hingorani, A D ^p   Kumari, M ^f   Kivimaki, M ^f   Mangino, M ^q,r   Spector, T D ^q,r   Jablonski, K A ^s   Houston, D K ^t   Kritchevsky, S B ^t   Lohman, K K ^u   Ahluwalia, T S ^v,w,x,aa   Sorensen T I A ^v,w,y,z   Pasko, D ^ab   Frayling, T M ^ab   Zgaga, L ^ac,ae,af   Campbell, H ^ac   Theodoratou, E ^ac   Fraser, R M ^ac   Wilson, J F ^ac   Rudan, I ^ac   Price, J F ^ac   McLachlan, S ^ac   Vitart, V ^ad   Navarro, P ^ad   Huffman, J E ^ad   Hayward, C ^ad   Wright, A F ^ad   Thiering, E ^ag,ah   Tiesler, C M T ^ag,ai   Heinrich, J ^ag   McCarthy, M I ^{aj,ak,al,am,an}   Ingelsson, E ^al,bm,bn   Cooper, C ^am,ay   Arden, N ^am,ay   Dupuis, J ^ao   Herzig, K H ^ap,aq,as   Sebert, S ^aq,ar   Alves, A C ^ar   Pouta, A ^f,au,av   Laitinen, J ^aw   Kleber, M E ^ax   Marz W ^ax,bw,by   Jameson, K ^ay   Osmond, C ^ay   Raitakari, O ^az,ba   Ripatti, S ^bb,bc   Lahti, J ^bd   Eriksson, J G ^{f,av,bs,bt,bu}   Penninx, B W ^bb,be   Billings, L K ^bf,bg,bh,bi   Florez, J C ^bf,bg,bh   Rejnmark, L ^bj   Langdahl, B L ^bj   Paternoster, L ^bk   Hernandez, D G ^bl   Byberg, L ^f   Michaelsson K ^f   Hagstrom E ^bm   Melhus, H ^bm   Ljunggren, O ^bm   Lind, L ^bm   Jula, A ^av,bo   Polasek, O ^bp   Salomaa, V ^av   Karlsson, M ^bq   Bandinelli, S ^br   Lehtimaki T ^bv   Wang, T J ^bx   Pilz, S ^by   Whittaker, J C ^bz   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY OF TROMSØ   (Norway)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f Department of Epidemiology and Biostatistics ^*  (Sweden)

^g Faculty of Medicine   (United Kingdom)

^h Imperial College London   (United Kingdom)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF GRONINGEN   (Netherlands)

^k UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^l Institute for Molecular Medicine Finland   (Finland)

^m SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ MEDICAL RESEARCH COUNCIL   (United Kingdom)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p Genetic Epidemiology Group   (United Kingdom)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r KING'S COLLEGE LONDON   (United Kingdom)

^s GEORGE WASHINGTON UNIVERSITY   (United States)

^t Department of Internal Medicine   (United States)

^u Division of Public Health Sciences   (United States)

^v WAKE FOREST SCHOOL OF MEDICINE   (United States)

^w Capital Region   (Denmark)

^x UNIVERSITY OF COPENHAGEN   (Denmark)

^y UNIVERSITY OF COPENHAGEN   (Denmark)

^z The Capital Region   (Denmark)

^aa GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^ab UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^ac Centre for Population Health Sciences   (United Kingdom)

^ad UNIVERSITY OF EDINBURGH   (United Kingdom)

^ae UNIVERSITY OF EDINBURGH   (United Kingdom)

^af TRINITY COLLEGE DUBLIN   (Ireland)

^ag INSTITUTE OF EPIDEMIOLOGY   (Germany)

^ah Division of Metabolic Diseases and Nutritional Medicine   (Germany)

^ai Institute of Medical Informatics Biometry and Epidemiology   (Germany)

^aj LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^ak UNIVERSITY OF OXFORD   (United Kingdom)

^al UNIVERSITY OF OXFORD   (United Kingdom)

^am NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^an UNIVERSITY OF OXFORD   (United Kingdom)

^ao FRAMINGHAM HEART STUDY   (United States)

^ap Institute of Biomedicine   (Finland)

^aq UNIVERSITY OF OULU   (Finland)

^ar Institute of Health Sciences   (Finland)

^as MEDICAL RESEARCH CENTER OULU   (Finland)

^at Unit of Primary Care   (Finland)

^au OULU UNIVERSITY HOSPITAL   (Finland)

^av NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^aw FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^ax UNIVERSITY OF HEIDELBERG   (Germany)

^ay UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^az UNIVERSITY OF TURKU   (Finland)

^ba TURKU UNIVERSITY HOSPITAL   (Finland)

^bb UNIVERSITY OF HELSINKI   (Finland)

^bc Hjelt Institute   (Finland)

^bd Institute of Behavioural Sciences   (Finland)

^be VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^bf MASSACHUSETTS GENERAL HOSPITAL   (United States)

^bg BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^bh HARVARD MEDICAL SCHOOL   (United States)

^bi NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^bj AARHUS UNIVERSITY HOSPITAL   (Denmark)

^bk UNIVERSITY OF BRISTOL   (United Kingdom)

^bl NATIONAL INSTITUTES OF HEALTH   (United States)

^bm UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^bn SCIENCE FOR LIFE LABORATORY   (Sweden)

^bo UPPSALA UNIVERSITY   (Sweden)

^bp UNIVERSITY OF SPLIT   (Croatia)

^bq LUND UNIVERSITY   (Sweden)

^br SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^bs VAASA CENTRAL HOSPITAL   (Finland)

^bt FOLKHÄLSAN RESEARCH CENTER   (Finland)

^bu HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^bv TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^bw SYNLAB ACADEMY   (Germany)

^bx VANDERBILT UNIVERSITY   (United States)

^by MEDICAL UNIVERSITY OF GRAZ   (Austria)

^bz GLAXOSMITHKLINE   (United Kingdom)

^ca UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^cb SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; 7-DEHYDROCHOLESTEROL REDUCTASE; CHOLESTANETRIOL 26 MONOOXYGENASE; CYP2R1 PROTEIN, HUMAN; OXIDOREDUCTASE; VITAMIN D;

ADOLESCENT; ADULT; AGED; ALLELE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CHILD; CYP24A1 GENE; CYP2R1 GENE; DHCR7 GENE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; BODY MASS; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D DEFICIENCY;

ADULT; BODY MASS INDEX; CHOLESTANETRIOL 26-MONOOXYGENASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84908324133     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70113-5     Document Type: Article

References (33)

1. Autier P, Boniol M, Pizot C, Mullie P Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2:76-89.
2. Bolland MJ, Grey A, Gamble GD, Reid IR The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014, 2:307-320.
3. Tamez H, Thadhani RI Vitamin D and hypertension: an update and review. Curr Opin Nephrol Hypertens 2012, 21:492-499.
4. Margolis KL, Ray RM, Van Horn L, et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative randomized trial. Hypertension 2008, 52:847-855.
5. Witham MD, Nadir MA, Struthers AD Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009, 27:1948-1954.
6. Forman JP, Scott JB, Ng K, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 2013, 61:779-785.
7. Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:1931-1942.
8. Davey Smith G, Ebrahim S 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 2003, 32:1-22.
9. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
10. Berry DJ, Vimaleswaran KS, Whittaker JC, Hingorani AD, Hyppönen E Evaluation of genetic markers as instruments for mendelian randomization studies on vitamin D. PLoS One 2012, 7:e37465.
11. Vimaleswaran KS, Berry DJ, Lu C, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013, 10:e1001383.
12. Chun RF, Lauridsen AL, Suon L, et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 2010, 95:3368-3376.
13. Jones G, Prosser DE, Kaufmann M 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys 2012, 523:9-18.
14. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 478:103-109.
15. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009, 41:666-676.
16. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009, 41:677-687.
17. Jones G, Strugnell SA, DeLuca HF Current understanding of the molecular actions of vitamin D. Physiol Rev 1998, 78:1193-1231.
18. Mathematical statistics and data analysis 1995, International Thomson Publishing, Belmont. J.A. Rice (Ed.).
19. Palmer TM, Lawlor DA, Harbord RM, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 2012, 21:223-242.
20. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008, 27:1133-1163.
21. Thomas DC, Lawlor DA, Thompson JR Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. Ann Epidemiol 2007, 17:511-513.
22. Kunutsor SK, Burgess S, Munroe PB, Khan H Vitamin D and high blood pressure: causal association or epiphenomenon?. Eur J Epidemiol 2014, 29:1-14.
23. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010, 152:307-314.
24. Witham MD, Price RJ, Struthers AD, et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 2013, 173:1672-1679.
25. Kupferschmidt K Uncertain verdict as vitamin D goes on trial. Science 2012, 337:1476-1478.
26. Freundlich M, Quiroz Y, Zhang Z, et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 2008, 74:1394-1402.
27. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP 1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
28. Schroten NF, Ruifrok WP, Kleijn L, et al. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J 2013, 166:357-364. e2.
29. Tiosano D, Schwartz Y, Braver Y, et al. The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR). J Bone Miner Res 2011, 26:2252-2260.
30. Mehrotra R, Kermah DA, Salusky IB, et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009, 76:977-983.
31. Mutt SJ, Karhu T, Lehtonen S, et al. Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D(3) via the NF-κB pathway. FASEB J 2012, 26:4400-4407.
32. Schooling CM, Au Yeung SL, Freeman G Mendelian randomization estimates may be inflated. J Am Coll Cardiol 2013, 61:1931.
33. Skaaby T, Husemoen LL, Martinussen T, et al. Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach. PLoS One 2013, 8:e57647.